High levels of stromal cell-derived factor-1α predict short-term progression of renal dysfunction in patients with coronary artery disease-Reference-Cited by-同舟云学术

High levels of stromal cell-derived factor-1α predict short-term progression of renal dysfunction in patients with coronary artery disease

Published:2019-03-04 Issue:7 Volume:23 Page:920-927
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Uematsu Manabu,Nakamura Takamitsu,Yoshizaki Toru,Watanabe Yosuke,Deyama Juntaro,Watanabe Kazuhiro,Kobayashi Tsuyoshi,Fujioka Daisuke,Saito Yukio,Nakamura Kazuto,Kawabata Kenichi,Obata Jun-ei,Kugiyama Kiyotaka

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10157-019-01722-9.pdf

Reference34 articles.

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J kidney Dis. 2002;39(2 Suppl 1):1–266.

2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–69.

3. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339–52.

4. Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.

5. Ronco C, Haapio M, House AA, Ms C, Anavekar N. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527–39.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial;Diabetologia;2024-09-14

2. Association of serum stromal cell-derived factor 1 levels with EZSCAN score and its derived indicators in patients with type 2 diabetes;Endocrine Connections;2022-04-01

3. Serum stromal cell-derived factor-1 levels are associated with diabetic kidney disease in type 2 diabetic patients;Endocrine Journal;2021

4. Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy;International Journal of Molecular Sciences;2020-05-27